Effect of omega-3-fatty acids versus placebo on clinical symptoms of patients with major depressive disorder

Phase 2

• Conditions: Major depressive disorder.; Severe depressive episode without psychotic symptoms

• Registration Number: IRCT201705249014N164
• Lead Sponsor: Vice-chancellor for Research and Technology, Hamadan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Age of 18 to 65 years; major depressive disorder
Exclusion criteria: Pregnancy or breastfeeding; narcotic addiction; psychosis.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Depressive symptoms. Timepoint: before intervention and 6 and 12 weeks after intervention. Method of measurement: using standard questionnaire.;Sleep disorder. Timepoint: before intervention and 6 and 12 weeks after intervention. Method of measurement: using standard questionnaire.;Social competencies. Timepoint: before intervention and 6 and 12 weeks after intervention. Method of measurement: using standard questionnaire.;Physical activity. Timepoint: before intervention and 6 and 12 weeks after intervention. Method of measurement: using standard questionnaire.;Cognitive performance. Timepoint: before intervention and 6 and 12 weeks after intervention. Method of measurement: using standard questionnaire.